Mangalam Drugs and Organics Ltd MANGALAM-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:25 PM IST
117.00quote price arrow down-0.50 (-0.43%)
Volume
49,373
52 week range
20.65 - 175.70

...

Loading . . .

KEY STATS

  • Open117.40
  • Day High119.40
  • Day Low116.00
  • Prev Close117.50
  • 52 Week High175.70
  • 52 Week High Date11/18/20
  • 52 Week Low20.65
  • 52 Week Low Date03/19/20
  • Market Cap26.41M
  • Shares Out15.83M
  • 10 Day Average Volume219,366.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change318.6

RATIOS/PROFITABILITY

  • EPS (TTM)19.51
  • P/E (TTM)6.00
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/21/2017
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest Mangalam Drugs and Organics Ltd News

There is no recent news for this security.

Latest MANGALAM-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Mangalam Drugs and Organics Limited is an India-based company, which is engaged in the manufacture of drugs, medicines and allied products. The Company's geographical segments include Domestic and Export. It also manufactures active pharmaceutical ingredients (APIs), intermediates and specialty chemicals. Its API products include Allopurinol, Amodiaquine HCl, Artemether, Atazanavir Sulfate, Bisoprolol Fumarate, Lumefantrine, Primaquine Phosphate and Pyronaridine...
Govardhan Dhoot
Chairman
Ajay Samant
Chief Financial Officer
Address
3Rd Floor
Rupam Building 239, P. D'mello Road
Mumbai
400001
India